Pharmacodynamics of immediate and delayed effects of paclitaxel: Role of slow apoptosis and intracellular drug retention

Cancer Research

Volumn 58, Issue 10, 1998, Pages 2141-2148

  Au, Jessie L S ^a,b   Li, Dong ^a   Gan, Yuebo ^a,b   Gao, Xiang ^a   Johnson, Andrew L ^a   Johnston, Jeffrey ^a   Millenbaugh, Nancy J ^a   Jang, Seong H ^a   Kuh, Hyo Jeong ^a   Chen, Chiung Tong ^a   Wientjes, M Guillaume ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; HISTONE; PACLITAXEL; RHODAMINE B;

APOPTOSIS; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CELL CULTURE; CHO CELL; CONTROLLED STUDY; CYTOTOXICITY; DNA HISTONE INTERACTION; DRUG RETENTION; HUMAN; HUMAN CELL; OVARY CANCER; PHARMACODYNAMICS; PHARYNX CANCER; PRIORITY JOURNAL; PROSTATE CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL SURVIVAL; CHO CELLS; CRICETINAE; HUMANS; PACLITAXEL; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 14444280360     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Rowinsky, E. K., Wright, M., Monsarrat, B., Lesser, G. J., and Donehower, R. C. Taxol. Pharmacology, metabolism and clinical implications. Cancer Surv., 17: 283-301, 1993.
2. Schiff, P. B., and Horwitz, S. B. Taxol assembles tubulin in the absence of exogenous guanosine 5′-triphosphate or microtubule-associated proteins. Biochemistry, 20: 3247-3252, 1981.
3. Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., and Wilson, L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res., 56: 816-825, 1996.
4. Jordan, M. A., Toso, R. J., Thrower, D., and Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc. Natl. Acad. Sci. USA, 90: 9552-9556, 1993.
5. Eisenhauer, E. A., ten Bakkel Huinink, W. W., Swenerton, K. D., Gianni, L., Myles, J., van der Burg, M. E. L., Kerr, I., Vermorken, J. B., Buser, K., Colombo, N., Bacon, M., Santabárbara, P., Onetto, N., Winograd, B., and Canetta, R. European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. J. Clin. Oncol., 12: 2654-2666, 1994.
6. Rowinsky, E. K., Donehower, R. C., Jones, J., and Tucker, R. W. Microtubule changes and cytotoxicity in leukemic cell lines treated with Taxol. Cancer Res., 48: 4093-4100, 1988.
7. Lopes, N. M., Adams, E. G., Pitts, T. W., and Bhuyan, B. K. Cell kill kinetics and cell cycle effects of Taxol on human and hamster ovarian cell lines. Cancer Chemother. Pharmacol., 32: 235-242, 1993.
8. Tishler, R. B., Geard, C. R., Hall, E. J., and Schiff, P. B. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res., 52: 3495-3497, 1992.
9. Kelland, L. R., and Abel, G. Comparative in vitro cytotoxicity of Taxol and taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines. Cancer Chemother. Pharmacol., 30: 444-450, 1992.
10. Lieberman, J. E., Cook, J. A., Lipschultz, C., Teague, D., Fisher, J., and Mitchell, J. B. Cytotoxic studies of paclitaxel (Taxol) in human tumor cell lines. Br. J. Cancer, 68: 1104-1109, 1993.
11. Milas, L., Hunter, N., Kurdoglu, B., Mason, K. A., Meyn, R. E., Stephens, L. C., and Peters, L. J. Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with Taxol. Cancer Chemother. Pharmacol., 35: 297-303, 1995.
12. Adler, L. M., Herzog, T. J., Williams, S., Rader, J. S., and Mutch, D. G. Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines. Cancer (Phila.), 74: 1891-1898, 1994.
13. Roberts, J. R., Allison, D. C., Donehower, R. C., and Rowinsky, E. W. Development of polyploidization in Taxol-resistant human leukemia cells in vitro. Cancer Res., 50: 710-716, 1990.
14. Cohen, J. J., and Duke, R. C. Glucocorticoid activation of calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol., 132: 38-42, 1984.
15. Hickman, J. A. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11: 121-139, 1992.
16. Lieberman, J., Cook, J. A., Lipschultz, C., Teague, D., Fisher, J., and Mitchell, J. B. The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol) in human tumor cell lines. Cancer Chemother. Pharmacol., 33: 331-339, 1994.
17. Nygren, P., Csoka, K., Jonsson, B., Fridborg, H., Bergh, J., Hagberg, H., Glimelius, B., Brodin, O., Tholander, B., Kreuger, A., Lonnerholm, G., Jakobsson, A., Olsen, L., Kristensen, J., and Larsson, R. The cytotoxic activity of Taxol in primary cultures of tumor cells from patients is partly mediated by Cremophor EL. Br. J. Cancer, 71: 478-481, 1995.
18. Pizao, P. E., Lyarun, D. M., Peters, G. P., van Ark-Otte, J., Winograd, B., Giaccone, G., and Pinedo, H. M. Growth, morphology and chemosensitivity studies on post-confluent cells cultured in "V"-bottomed microtiter plates. Br. J. Cancer, 66: 660-665, 1992.
19. Darzynkiewica, Z., Robinson, J. P., and Crissman, H. A. Methods in cell biology: flow cytometry, Ed. 2, Part A, pp. 32-36. New York: Academic Press, 1995.
20. Holford, N. H. G., and Sheiner, L. B., Kinetics of the pharmacologic response. Pharmacol. Ther., 16: 143-166, 1982.
21. Saunders, D. E., Lawrence, W. D., Christensen, C., Wappler, N. L., Ruan, H., and Deppe, G. Paclitaxel-induced apoptosis in MCF-7 breast cancer cells. Int. J. Cancer, 70: 214-220, 1997.
22. Gan, Y., Wientjes, M. G., Schuller, D. E., and Au, J. L-S. Pharmacodynamics of Taxol in human head and neck tumors. Cancer Res., 56: 2086-2093, 1996.
23. Baguley, B. C., Marshall, E. S., Whittaker, J. R., Dotchin, M. C., Nixon, J., McCrystal, M. R., Finlay, G. J., Matthews, J. H. L., Holdaway, K. M., and van Zijl, P. Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumor cells cultured from patients with ovarian cancer. Eur. J. Cancer, 31: 230-237, 1995.
24. Vukovic, V., and Tannock, I. F. Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone, and topotecan. Br. J. Cancer, 75: 1167-1172, 1997.
25. Liebman, J. E., Hahn, S. M., Cook, J. A., Lipschultz, C., Mitchell, J. B., and Kaufman, D. C. Glutathione depletion by L-buthionine sulfoximine antagonizes Taxol cytotoxicity. Cancer Res., 53: 2066-2070, 1993.
26. Hui, A., Kulkarni, G. V., Hunter, W. L., McCulloch, C. A., and Cruz, T. F. Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytes. Arthritis Rheumatism, 40: 1073-1084, 1997.
27. Silvestrini, R., Zaffaroni, N., Orlandi, L., and Oriana, S. In vitro cytotoxic activity of Taxol and Taxotere on primary cultures and established cell lines of human ovarian cancer. Stem Cells, 11: 528-535, 1993.
28. Liebman, J. E., Cook, J. A., Teague, D., Fisher, J., and Mitchell, J. B. Cycloheximide inhibits the cytotoxicity of paclitaxel (Taxol). Anti-Cancer Drugs, 5: 287-292, 1994.
29. Chen, C. T., Au, J. L-S., Gan, Y., and Wientjes, M. G. Differential time dependency of antiproliferative and apoptotic effects of Taxol in human prostate tumors. Urol. Oncol., 3: 11-17, 1997.
30. Song, D., Hsu, L-F., and Au, J. L-S. Binding of Taxol to plastic and glass containers and protein under in vitro conditions. J. Pharm. Sci., 85: 29-31, 1996.
31. Sparreboom, A., van Tellingen, O., Nooijen, W. J., and Beijnen, J. H. Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL. Cancer Res., 56: 2112-2115, 1996.